Listen on the go
CORRECT!
Next question
touchENDOCRINOLOGY touchENDOCRINOLOGY

Start Learning

Touch Loading image
JOURNALS
Start Learning
Q&A with Dr Mary Ellen Vajravelu: touchENDOCRINOLOGY Future Leader 2025
JOURNALS
Start Learning
Q&A with Dr Gordon Sloan: touchENDOCRINOLOGY Future Leader 2025
Endometriosis and Uterine Diseases
JOURNALS
Start Learning
The 11th Annual SEUD Congress: Modern Management of Endometriosis and Uterine Diseases
Eneboparatide meets primary endpoint in adults with hypoparathyroidism: CALYPSO topline phase III results
JOURNALS
Start Learning
Eneboparatide meets primary endpoint in adults with hypoparathyroidism: CALYPSO topline phase III results
JOURNALS
Start Learning
Connecting endocrinology across the life course: The ESE and ESPE join forces
touchFEATURE
Start Learning
Preventing Heart Failure in People with Diabetes: Guidance for Early Identification and Management
Sponsored content
JOURNALS
Start Learning
Greatest Hits of 2024
JOURNALS
Start Learning
The International Evidence-based Guidelines for the Assessment and Management of Polycystic Ovary Syndrome: An Exemplar of Person-centred Care
touchEXPERT OPINIONS
Start Learning
Primary biliary cholangitis: Appraising the changing therapeutic landscape
CE/CME ACCREDITED
JOURNALS
Start Learning
Dry Eye in Diabetes: The Indian Diabetic and Endocrine Eye Diseases (INDEED) Review

to view Favourites, Keep Notes and Track CME Credits

Favourites
Expanded treatment choices in obesity care
View
Automated insulin delivery (AID) in children with type 1 diabetes: Outcomes and education strategies in real-world practice
View
Bridging Medical Specialities in the Management of Polycystic Ovary Syndrome: Integrating Lessons from Sodium–glucose Cotransporter-2 Inhibitors into a Holistic Approach
View
WAPO launches Blogs & Vlogs 2025 to spotlight global pituitary health challenges
View
New Insights into the Pleiotropic Actions of Dipeptidyl Peptidase-4 Inhibitors Beyond Glycaemic Control
View
Q&A with Dr Jennifer Snaith: touchENDOCRINOLOGY Future Leader 2025
View
MiniMed 780G safe and effective for children 2-6 years with type 1 diabetes
View
Changes in Urinary Aquaporin 2 and Serum Sodium After Catheterization in Elderly Patients with Syndrome of Inappropriate Antidiuretic Hormone and Urinary Retention: A Preliminary Hospital-based Study in Yangon, Myanmar
View
Eneboparatide meets primary endpoint in adults with hypoparathyroidism: CALYPSO topline phase III results
View
Turning your Clinical Expertise into Business Success
View
Copied to clipboard!
accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Sponsored Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72
Close Popup